
Global Heart Failure POC and LOC Devices Market Size Study, By Type (Proteomic Testing, Metabolomic Testing, Genomic Testing), By Technology (Microfluidics, Array-based Systems, Others), By End-use (Clinics, Hospitals, Home, Assisted Living Healthcare Fac
Description
Global Heart Failure POC and LOC Devices Market Size Study, By Type (Proteomic Testing, Metabolomic Testing, Genomic Testing), By Technology (Microfluidics, Array-based Systems, Others), By End-use (Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), and Regional Forecasts 2022-2032
The Global Heart Failure POC and LOC Devices Market is valued at approximately USD 88.27 million in 2023 and is expected to grow at a CAGR of 15.09% over the forecast period 2024-2032. Driven by advancements in microfluidics and lab-on-a-chip (LOC) technologies, the market is revolutionizing diagnostics, particularly for heart failure. These devices facilitate rapid, cost-effective, and high-throughput testing, providing real-time insights into cardiac health. The rising prevalence of cardiovascular diseases (CVD) globally and an increasing demand for early detection and personalized treatment further support the market's growth trajectory.
The prevalence of diabetes and cardiovascular diseases has emerged as a major driver for the adoption of point-of-care (POC) diagnostics. For example, approximately 30% of diabetic patients develop heart failure, highlighting the urgent need for accessible and effective diagnostic tools. Innovations such as Roche Diagnostics' NT-proBNP test for early detection of heart failure in type 2 diabetes (T2D) patients are transforming preventive care. By enabling early intervention, these solutions improve clinical outcomes and reduce hospital admissions, particularly in resource-constrained settings.
Technological advancements, such as microfluidics-based LOC systems, allow precise handling of small biological samples for detecting key biomarkers like NT-proBNP, Troponin I, and Troponin T, which are critical for heart failure diagnosis. The integration of these technologies with artificial intelligence (AI) further enhances their accuracy and efficiency. For instance, algorithms like CoDe-ACS combine patient data and metrics to predict cardiac risks, accelerating the decision-making process.
Regionally, North America dominates the market due to its advanced healthcare infrastructure, strong R&D investments, and increasing adoption of POC diagnostics in clinical and homecare settings. The Asia Pacific region, however, is projected to grow at the fastest rate, driven by rising healthcare awareness, the prevalence of chronic diseases, and ongoing investments in medical infrastructure.
Despite the promising growth, challenges such as undefined reimbursement frameworks for multi-analyte devices and adoption barriers in emerging economies remain significant hurdles. Nevertheless, ongoing innovations and government initiatives, like the KardiaTool project in Europe, aim to address these issues and expand access to affordable diagnostic technologies.
Major Market Players Included in this Report Are:
1. Abbott
2. Danaher
3. Siemens Healthineers
4. F. Hoffmann-La Roche Ltd
5. Quidel Corporation
6. bioMérieux S.A
7. Trinity Biotech
8. Abaxis, Inc
9. Philips Healthcare
10. Ultromics
11. Bio-Rad Laboratories
12. NanoDx, Inc.
13. Randox Laboratories
14. Ortho Clinical Diagnostics
15. Specific Diagnostics
The Detailed Segments and Sub-segments of the Market Are Explained Below:
By Type:
• Proteomic Testing
• Metabolomic Testing
• Genomic Testing
By Technology:
• Microfluidics
• Array-based Systems
• Others
By End-use:
• Clinics
• Hospitals
• Home
• Assisted Living Healthcare Facilities
• Laboratory
By Region:
North America
• U.S.
• Canada
• Mexico
Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
Asia Pacific
• Japan
• China
• India
• Australia
• Thailand
• South Korea
Latin America
• Brazil
• Argentina
Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Kuwait
Years Considered for the Study Are as Follows:
• Historical Year – 2022
• Base Year – 2023
• Forecast Period – 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 Years (2022-2032).
• Annualized Revenue and Regional Analysis for Each Market Segment.
• Comprehensive Geographical Landscape Analysis with Country-level Details.
• Competitive Landscape with Market Share Analysis and Key Player Profiles.
• Detailed Business Strategies and Recommendations for Future Market Approach.
• Demand-side and Supply-side Analysis of the Market.
• Analysis of Technological Advancements and Emerging Trends.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Table of Contents
285 Pages
- Chapter 1. Global Heart Failure POC and LOC Devices Market Executive Summary
- 1.1. Global Heart Failure POC and LOC Devices Market Size & Forecast (2022-2032)
- 1.2. Regional Summary
- 1.3. Segmental Summary
- 1.3.1. By Type
- 1.3.2. By Technology
- 1.3.3. By End-use
- 1.4. Key Trends
- 1.5. Recession Impact
- 1.6. Analyst Recommendation & Conclusion
- Chapter 2. Global Heart Failure POC and LOC Devices Market Definition and Research Assumptions
- 2.1. Research Objective
- 2.2. Market Definition
- 2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
- 2.3.3.1. Availability
- 2.3.3.2. Infrastructure
- 2.3.3.3. Regulatory Environment
- 2.3.3.4. Market Competition
- 2.3.3.5. Economic Viability (Consumer’s Perspective)
- 2.3.4. Demand Side Analysis
- 2.3.4.1. Regulatory Frameworks
- 2.3.4.2. Technological Advancements
- 2.3.4.3. Environmental Considerations
- 2.3.4.4. Consumer Awareness & Acceptance
- 2.4. Estimation Methodology
- 2.5. Years Considered for the Study
- 2.6. Currency Conversion Rates
- Chapter 3. Global Heart Failure POC and LOC Devices Market Dynamics
- 3.1. Market Drivers
- 3.1.1. Rising prevalence of cardiovascular diseases globally
- 3.1.2. Technological advancements in POC and LOC diagnostics
- 3.1.3. Growing adoption of decentralized healthcare solutions
- 3.2. Market Challenges
- 3.2.1. Lack of defined reimbursement frameworks for multi-analyte diagnostics
- 3.2.2. High cost of advanced diagnostic devices
- 3.3. Market Opportunities
- 3.3.1. Increased R&D investments in LOC-based technologies
- 3.3.2. Growing demand for personalized medicine and early diagnostics
- 3.3.3. Expansion of healthcare infrastructure in emerging economies
- Chapter 4. Global Heart Failure POC and LOC Devices Market Industry Analysis
- 4.1. Porter’s 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economic
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
- 4.3. Top Investment Opportunity
- 4.4. Top Winning Strategies
- 4.5. Disruptive Trends
- 4.6. Industry Expert Perspective
- 4.7. Analyst Recommendation & Conclusion
- Chapter 5. Global Heart Failure POC and LOC Devices Market Size & Forecast by Type (2022-2032)
- 5.1. Segment Dashboard
- 5.2. Global Heart Failure POC and LOC Devices Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 5.2.1. Proteomic Testing
- 5.2.2. Metabolomic Testing
- 5.2.3. Genomic Testing
- Chapter 6. Global Heart Failure POC and LOC Devices Market Size & Forecast by Technology (2022-2032)
- 6.1. Segment Dashboard
- 6.2. Global Heart Failure POC and LOC Devices Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 6.2.1. Microfluidics
- 6.2.2. Array-based Systems
- 6.2.3. Others
- Chapter 7. Global Heart Failure POC and LOC Devices Market Size & Forecast by End-use (2022-2032)
- 7.1. Segment Dashboard
- 7.2. Global Heart Failure POC and LOC Devices Market: End-use Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 7.2.1. Clinics
- 7.2.2. Hospitals
- 7.2.3. Home
- 7.2.4. Assisted Living Healthcare Facilities
- 7.2.5. Laboratory
- Chapter 8. Global Heart Failure POC and LOC Devices Market Size & Forecast by Region (2022-2032)
- 8.1. North America Heart Failure POC and LOC Devices Market
- 8.1.1. U.S. Heart Failure POC and LOC Devices Market
- 8.1.2. Canada Heart Failure POC and LOC Devices Market
- 8.1.3. Mexico Heart Failure POC and LOC Devices Market
- 8.2. Europe Heart Failure POC and LOC Devices Market
- 8.2.1. UK Heart Failure POC and LOC Devices Market
- 8.2.2. Germany Heart Failure POC and LOC Devices Market
- 8.2.3. France Heart Failure POC and LOC Devices Market
- 8.2.4. Italy Heart Failure POC and LOC Devices Market
- 8.2.5. Spain Heart Failure POC and LOC Devices Market
- 8.2.6. Denmark Heart Failure POC and LOC Devices Market
- 8.2.7. Sweden Heart Failure POC and LOC Devices Market
- 8.2.8. Norway Heart Failure POC and LOC Devices Market
- 8.3. Asia Pacific Heart Failure POC and LOC Devices Market
- 8.3.1. Japan Heart Failure POC and LOC Devices Market
- 8.3.2. China Heart Failure POC and LOC Devices Market
- 8.3.3. India Heart Failure POC and LOC Devices Market
- 8.3.4. Australia Heart Failure POC and LOC Devices Market
- 8.3.5. Thailand Heart Failure POC and LOC Devices Market
- 8.3.6. South Korea Heart Failure POC and LOC Devices Market
- 8.4. Latin America Heart Failure POC and LOC Devices Market
- 8.4.1. Brazil Heart Failure POC and LOC Devices Market
- 8.4.2. Argentina Heart Failure POC and LOC Devices Market
- 8.5. Middle East & Africa Heart Failure POC and LOC Devices Market
- 8.5.1. Saudi Arabia Heart Failure POC and LOC Devices Market
- 8.5.2. UAE Heart Failure POC and LOC Devices Market
- 8.5.3. South Africa Heart Failure POC and LOC Devices Market
- 8.5.4. Kuwait Heart Failure POC and LOC Devices Market
- Chapter 9. Competitive Intelligence
- 9.1. Key Company SWOT Analysis
- 9.1.1. Abbott
- 9.1.2. Danaher
- 9.1.3. Siemens Healthineers
- 9.2. Top Market Strategies
- 9.3. Company Profiles
- 9.3.1. F. Hoffmann-La Roche Ltd.
- 9.3.2. Quidel Corporation
- 9.3.3. bioMérieux S.A
- 9.3.4. Trinity Biotech
- 9.3.5. Abaxis, Inc.
- 9.3.6. Philips Healthcare
- 9.3.7. Bio-Rad Laboratories
- 9.3.8. NanoDx, Inc.
- 9.3.9. Ortho Clinical Diagnostics
- 9.3.10. Specific Diagnostics
- Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
- List of Tables
- 1. Global Heart Failure POC and LOC Devices Market Estimates by Type (2022-2032)
- 2. Global Heart Failure POC and LOC Devices Market Estimates by Technology (2022-2032)
- 3. Global Heart Failure POC and LOC Devices Market Estimates by End-use (2022-2032)
- 4. Global Heart Failure POC and LOC Devices Market Regional Analysis (2022-2032)
- 5. U.S. Heart Failure POC and LOC Devices Market Size and Forecast, By Type, 2022-2032
- 6. Germany Heart Failure POC and LOC Devices Market Size and Forecast, By Technology, 2022-2032
- 7. Japan Heart Failure POC and LOC Devices Market Size and Forecast, By End-use, 2022-2032
- 8. North America Heart Failure POC and LOC Devices Market Revenue by Type (2022-2032)
- 9. Europe Heart Failure POC and LOC Devices Market Revenue by Technology (2022-2032)
- 10. Asia Pacific Heart Failure POC and LOC Devices Market Revenue by End-use (2022-2032)
- 11. Brazil Heart Failure POC and LOC Devices Market Estimates, By Type, 2022-2032
- 12. Middle East Heart Failure POC and LOC Devices Market Analysis, By Technology, 2022-2032
- 13. Global Proteomic Testing Market Size, 2022-2032 (USD Million)
- 14. Global Metabolomic Testing Market Size, 2022-2032 (USD Million)
- 15. Global Genomic Testing Market Size, 2022-2032 (USD Million)
- 16. Microfluidics Technology Adoption Trends (2024-2032)
- 17. Array-Based Systems Revenue Share, By Region (2022-2032)
- 18. Home Testing Devices Market Growth in Heart Failure Diagnostics (2022-2032)
- 19. Regional Heart Failure Incidence by Age Group (2022-2032)
- 20. Hospitals and Clinics Revenue Share for Heart Failure POC Devices (2022-2032)
- 21. Global Heart Failure POC and LOC Devices Market Competitive Landscape Analysis (2024)
- 22. Regulatory Framework for POC and LOC Devices Across Regions
- 23. Investment in Microfluidics-Based Heart Failure Diagnostics, 2024-2032
- 24. Emerging Trends in Personalized Heart Failure Management Solutions
- 25. Comparison of NT-proBNP Testing and Troponin Markers by Sensitivity
- This list is not complete; the final report contains over 100 tables. The list may be updated in the final deliverable.
- List of Figures
- 1. Global Heart Failure POC and LOC Devices Market Size, 2022-2032 (USD Million)
- 2. Global Market Growth Rate by Segment (2024-2032)
- 3. Heart Failure POC and LOC Devices Market: Key Trends and Dynamics, 2024
- 4. Proteomic Testing Market Share in Heart Failure Diagnostics, 2024
- 5. Metabolomic Testing Market Growth Trajectory, 2022-2032
- 6. Genomic Testing Trends in Cardiovascular Applications, 2022-2032
- 7. Microfluidics Technology Adoption Across Major Regions, 2022-2032
- 8. Array-Based Systems: Revenue Comparison by Region, 2024
- 9. Point-of-Care Testing Device Penetration in Clinical Settings, 2022-2032
- 10. Regional Insights: Heart Failure POC and LOC Devices Adoption, 2024
- 11. U.S. Heart Failure POC and LOC Devices Market Trends, 2022-2032
- 12. Germany: Adoption of LOC Platforms in Clinics and Homecare, 2024
- 13. Asia Pacific Market Growth Drivers for Heart Failure Diagnostics, 2022-2032
- 14. Technology Comparison: Microfluidics vs. Array-Based Systems, 2024
- 15. NT-proBNP Testing: Adoption and Growth Rate, 2024-2032
- 16. Clinics vs. Home Use: Market Share in End-use Segment, 2022-2032
- 17. Regional Prevalence of Cardiovascular Diseases, 2022-2032
- 18. Investment Trends in Heart Failure Diagnostics, By Region, 2022-2032
- 19. Global Aging Population Growth and Heart Failure Incidence, 2022-2032
- 20. Adoption of Home-Based Testing Devices for Heart Failure, 2022-2032
- 21. Role of AI and Digital Health in Enhancing LOC and POC Testing Accuracy
- 22. Strategic Initiatives by Key Market Players, 2022-2032
- 23. Competitive Positioning of Key Companies in Heart Failure Diagnostics
- 24. Evolution of Lab-On-Chip Technologies in Cardiovascular Diagnostics
- 25. Contribution of Government Initiatives to Market Growth, 2024
- This list is not complete; the final report contains over 50 figures. The list may be updated in the final deliverable.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.